News

Video

ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases

Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.

Taylor Strange, DO, shared insights on improving astigmatism outcomes using the LENSAR Ally femtosecond laser system in light adjustable lens (LAL) patients in a presentation at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California.

Strange outlined the motivation behind transitioning away from manual techniques. “I was motivated to explore femtosecond laser astigmatism correction, because prior to me adopting femtosecond laser vision correction, I would do manual LRIs, and my manual LRIs weren't that effective. My enhancement rate was too high for me, unacceptable at about 10%, so I wanted to look into technology that would allow me to deliver a better, premium outcome with less enhancements.”

His study demonstrated significant benefits with femtosecond laser-assisted correction. “It was great to see that the reduction in the astigmatism and the number of adjustments I did with light adjustable lens was significantly improved statistically in my study.” Patients who received astigmatism correction with the LENSAR Ally system required fewer LAL adjustments, translating into tangible efficiency gains. “The outcomes of this study would really help a surgeon to adopting into femtosecond laser treatment, especially for light adjustable lens patients, to really look forward to having less adjustments performed on these patients, which means less chair time and quicker to their end point.”

Reflecting on his experience, Strange noted, “I noticed a difference compared to not doing femtosecond laser, that I got much more improvement, again, with less chair time and better results.” He emphasized the broader impact on premium cataract surgery: “I'm a big proponent of using the Ally LENSAR system for all premium IOLs. It gives you better astigmatism management, which you can get to your refractive outcome better in my hands versus using manual LRIs.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
© 2025 MJH Life Sciences

All rights reserved.